Sage Journals: Discover world-class research

Open access

Review article

First published 2022

The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma

Omar Albanyan, Julio Chavez, Javier Munoz

Therapeutic Advances in Hematology

Open access

Research article

First published 2024

Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects

Jingyi Li, Juan Mu, Jia Wang [...]

Cell Transplantation

Open access

Review article

First published 2025

The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature Review

Andrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2025

Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL)

Baptiste Fulbert, Théo Vincent, Justine Clarenne [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs

Jiangtao Li, Wenxuan Huo, Yang Yang [...]

Cell Transplantation

Retricted access

Review article

First published 2022-12

New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma

Donald C. Moore, Matthew R. Peery, Katherine A. Tobon [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2021

The use of tafasitamab in diffuse large B-cell lymphoma

Johannes Düll, Max Topp, Gilles Salles

Therapeutic Advances in Hematology

Open access

Review article

First published 2019

The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma

Sarah Tomassetti, Robert Chen, Savita Dandapani

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2025-10

Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide,etoposide,and cisplatin (DICEP)

Kevin Thai, Jennifer Jupp, Deonne Dersch-Mills [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2022

Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma

Fabian Frontzek, Imke Karsten, Norbert Schmitz [...]

Therapeutic Advances in Hematology

Search results